These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34643927)

  • 1. Corticosteroids for COVID-19: worth it or not?
    Akter F; Araf Y; Hosen MJ
    Mol Biol Rep; 2022 Jan; 49(1):567-576. PubMed ID: 34643927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylmethimazole is a candidate drug for the treatment of severe forms of coronavirus disease 2019 (COVID-19) as well as other virus-induced "cytokines storm".
    Giuliani C; Bucci I; Napolitano G
    Med Hypotheses; 2021 Jan; 146():110473. PubMed ID: 33385879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines and COVID-19: friends or foes?
    Rokni M; Hamblin MR; Rezaei N
    Hum Vaccin Immunother; 2020 Oct; 16(10):2363-2365. PubMed ID: 32841579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Influence of Corticosteroids, Immunosuppressants and Biologics on Patients With Inflammatory Bowel Diseases, Psoriasis and Rheumatic Diseases in the Era of COVID-19: A Review of Current Evidence.
    Zhang M; Bai X; Cao W; Ji J; Wang L; Yang Y; Yang H
    Front Immunol; 2021; 12():677957. PubMed ID: 34335579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic corticosteroids for management of COVID-19: Saving lives or causing harm?
    FakhriRavari A; Jin S; Kachouei FH; Le D; Lopez M
    Int J Immunopathol Pharmacol; 2021; 35():20587384211063976. PubMed ID: 34923856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: A systematic review and meta-analysis.
    Wang J; Yang W; Chen P; Guo J; Liu R; Wen P; Li K; Lu Y; Ma T; Li X; Qin S; Zhang Y; Wang Y
    PLoS One; 2021; 16(4):e0249481. PubMed ID: 33882090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid Use.
    Arca KN; Smith JH; Chiang CC; Starling AJ; Robertson CE; Halker Singh RB; Schwedt TJ; Kissoon NR; Garza I; Rozen TD; Boes CJ; Whealy MA; VanderPluym JH
    Headache; 2020 Sep; 60(8):1558-1568. PubMed ID: 32648592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategies of COVID-19: A rheumatology perspective.
    Drosos AA; Pelechas E; Voulgari PV
    Eur J Intern Med; 2022 Aug; 102():17-23. PubMed ID: 35610165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can steroids reverse the severe COVID-19 induced "cytokine storm"?
    Kolilekas L; Loverdos K; Giannakaki S; Vlassi L; Levounets A; Zervas E; Gaga M
    J Med Virol; 2020 Nov; 92(11):2866-2869. PubMed ID: 32530507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
    Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F;
    Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid administration for viral pneumonia: COVID-19 and beyond.
    Yang JW; Yang L; Luo RG; Xu JF
    Clin Microbiol Infect; 2020 Sep; 26(9):1171-1177. PubMed ID: 32603802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and corticosteroids: a narrative review.
    El-Saber Batiha G; Al-Gareeb AI; Saad HM; Al-Kuraishy HM
    Inflammopharmacology; 2022 Aug; 30(4):1189-1205. PubMed ID: 35562628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
    Front Immunol; 2021; 12():749291. PubMed ID: 34867978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pulse-dose and high-dose corticosteroids with no corticosteroid treatment for COVID-19 pneumonia in the intensive care unit.
    Yaqoob H; Greenberg D; Hwang F; Lee C; Vernik D; Manglani R; Wang Z; Murad MH; Chandy D; Epelbaum O
    J Med Virol; 2022 Jan; 94(1):349-356. PubMed ID: 34542192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives.
    Sagris M; Theofilis P; Antonopoulos AS; Tsioufis C; Oikonomou E; Antoniades C; Crea F; Kaski JC; Tousoulis D
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Profiling of COVID-19 in Correlation with SARS and MERS.
    Khalil BA; Shakartalla SB; Goel S; Madkhana B; Halwani R; Maghazachi AA; AlSafar H; Al-Omari B; Al Bataineh MT
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids: A boon or bane for COVID-19 patients?
    Sen S; Singh B; Biswas G
    Steroids; 2022 Dec; 188():109102. PubMed ID: 36029810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid treatment in COVID-19 modulates host inflammatory responses and transcriptional signatures of immune dysregulation.
    Pinski AN; Steffen TL; Zulu MZ; George SL; Dickson A; Tifrea D; Maroney KJ; Tedeschi N; Zhang Y; Scheuermann RH; Pinto AK; Brien JD; Messaoudi I
    J Leukoc Biol; 2021 Dec; 110(6):1225-1239. PubMed ID: 34730254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.
    Li H; Chen C; Hu F; Wang J; Zhao Q; Gale RP; Liang Y
    Leukemia; 2020 Jun; 34(6):1503-1511. PubMed ID: 32372026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review of the Evidence for Corticosteroids in COVID-19.
    Johns M; George S; Taburyanskaya M; Poon YK
    J Pharm Pract; 2022 Aug; 35(4):626-637. PubMed ID: 33719698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.